Search
for
Sort by
Research 271–300 of 1000+
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- An overview of management of drug-induced hair and nail disorders
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- The PDGF/PDGFR pathway as a drug target
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- JAK Inhibitors for Treatment of Alopecia Areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Alopecia in general medicine
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Alopecia Areata
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Modern Management Approaches for Alopecia Areata
- Update: baricitinib for alopecia areata
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia